Effect of C21 on Forearm Blood Flow

Clinical trial NCT05277922 · COMPLETED

Trial details

NCT number: NCT05277922
Sponsor: Vicore Pharma AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Study Vasodilatory Effects of C21

Start date: 2022-04-28
Primary completion: 2022-05-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.